Molecular Immunology

Inverted Fab2s (IFab2s): Engineering and expression of novel, dimeric molecules, with a molecular weight of 100 000
pp. 1095-1102(8)
Authors: Speck R.R.; Couto J.R.; Godwin S.G.; Christian R.B.; Kiwan R.; Ceriani R.L.; Peterson J.A.

Neutralizing murine monoclonal anti-interleukin-10 antibodies enhance binding of antibodies against a different epitope
pp. 1103-1111(9)
Authors: Sabat R.; Seifert M.; Volk H.-D.; Glaser R.W.

Expression, purification and immunochemical characterization of recombinant bovine beta-lactoglobulin, a major cow milk allergen
pp. 1113-1118(6)
Authors: Chatel J.-M.; Bernard H.; Clement G.; Frobert Y.; Batt C.A.; Gavalchin J.; Peltre G.; Wal J.-M.

The conserved lymphokine element-0 in the IL5 promoter binds to a high mobility group-1 protein
pp. 1119-1125(7)
Authors: Marrugo J.; Marsh D.G.; Ghosh B.

Expression of recombinant CD59 with an N-terminal peptide epitope facilitates analysis of residues contributing to its complement-inhibitory function
pp. 1127-1134(8)
Authors: Quansheng Z.; Ji Z.; Husler T.; Sims P.J.

Two chemotactic factors, C5a and MIP-1, dramatically alter the mortality from zymosan-induced multiple organ dysfunction syndrome (MODS): C5a contributes to MODS while MIP-1 has a protective role
pp. 1135-1137(3)
Authors: Miller C.G.; Cook D.N.; Kotwal G.J.

The regulated expression of cell cycle-related proteins as B-lymphocytes enter and progress through the G₁ cell cycle stage following delivery of complete versus partial activation stimuli
pp. 1139-1151(13)
Authors: Reid S.; Snow E.C.